| |
N
|
Age median (years)
|
Q1 (years)
|
Q3 (years)
|
min; max (years)
|
|---|
|
GCT patients
|
177
|
38
|
33;
|
46
|
19; 80
|
|
Seminoma
|
112
|
39
|
34.5
|
48.5
|
19; 80
|
|
Nonseminoma
|
65
|
35
|
29
|
41
|
19; 62
|
|
preoperative subgroup
|
83
|
38
|
33
|
47
|
19; 80
|
|
GCT main group
|
165
|
38
|
32
|
47
|
19; 80
|
|
Cohort 2
|
84
|
45
|
36
|
59
|
17; 82
|
|
Cohort 3
|
237
|
66
|
53
|
76
|
18; 94
|
- cohort 2 denotes control group consisting of patients with non-neoplastic scrotal diseases; cohort 3 denotes control group 2 consisting of male urologic patients with non-testicular and non-neoplastic diseases
- Q1 first quartile, Q3 third quartile
